Certified by Founder
Lodge
Calida Therapeutics
start up
France
- Ville de Paris, Île-de-France
- 07/04/2023
- Seed
- $2,183,000
Calida Therapeutics operates as a biotechnology company. Calida Therapeutics develops monoclonal antibodies to treat and prevent thrombo-inflammatory disorders.
- Industry Biotechnology Research
- Website N/A
- LinkedIn https://www.linkedin.com/company/calida-therapeutics/
Deep Blue Medical Advances, Inc. | $5,600,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Ideally | $10,000,000 | (Apr 22, 2026)
Monk | $25,000,000 | (Apr 22, 2026)
Reliable Robotics Corporation | $160,000,000 | (Apr 22, 2026)
Humble Robotics | $24,000,000 | (Apr 22, 2026)
Sinai.ai | $1,450,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)
Exergy3 Limited | $13,523,900 | (Apr 22, 2026)
Syenta | $26,000,000 | (Apr 22, 2026)
urfuture | $2,299,785 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)